Anastrozole is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer.Anastrozole is indicated for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast ca..